MedPath

To see the effect of 2 medicines namely Dashmoola Amritadi Kwatha and Shallaki Guggulu in the treatment of disease Amavata(Rheumatoid Arthritis)

Phase 2
Conditions
Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
Registration Number
CTRI/2019/09/021115
Lead Sponsor
Ayurvedic and Unani Tibbia College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients willing for trial.

2.patients will be selected randomly irrespective of sex, occupation and socio-economic status.

3.Patients suffering from disease since at least 1 years.

4.Subjects having classical features of Amavata like Angamarda, Aruchi,Trishna, Hrillasa, Alasya, Gaurava, Jwara, Shoola, Shotha.

5.The patients should fulfil the 2010 ACR(American College of Rheumatology) EULAR (European League Against Rheumatism Criteria) criteria for rheumatoid arthritis.

Exclusion Criteria

Patients having Chronicity of more than 10 yrs.

2.Patients having Severe crippling bone deformity.

3.Patients having associated Cardiac disease, pulmonary tuberculosis and pregnant women and lactating mother.

4.patients having another type of arthropathy such as neoplasm of spine, gout, ankylosing spondylitis etc.

5.Juvenile rheumatoid arthritis.

6.Severely deformed joints.

7.Age below 30 and above 60.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response in PainTimepoint: Followup at 15 days interval
Secondary Outcome Measures
NameTimeMethod
Overall improvement in Quality of Life of patientsTimepoint: Follow up at 15 days interval
© Copyright 2025. All Rights Reserved by MedPath